On Thursday, Nexalin Technology, Inc (NASDAQ:NXL) (NASDAQ:NXLIW) announced results from a clinical trial of its Deep Intracranial Frequency Stimulation (DIFS) technology for mild Alzheimer’s disease.
Let's now turn to a small cap. And the next company is next-generation memory, is a real-world momentum semiconductor developer. Weebit Nano recently published its 2025 reports detailing its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results